Plasma insulin-like growth factor-I, insulin-like growth factor-binding proteins, and prostate cancer risk: a prospective study.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Journal of the National Cancer Institute

• Publication date

  2000-12-06

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/JNCI/92.23.1910PMID 11106682
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Insulin-like growth factor I correlations to changes of the hormonal status in puberty and age.

  2009cited by this paper
• Energy balance and cancer: the role of insulin and insulin-like growth factor-I

  2001cited by this paper
• Re: plasma insulin-like growth factor-I, insulin-like growth factor-binding proteins, and prostate cancer risk: a prospective study.

  2001cited by this paper
• Leptin is associated with increased prostate cancer risk: a nested case-referent study.

  2001cited by this paper
• Hormones and diet: low insulin-like growth factor-I but normal bioavailable androgens in vegan men

  2000cited by this paper
• Serum C-peptide, insulin-like growth factor (IGF)-I, IGF-binding proteins, and colorectal cancer risk in women.

  2000cited by this paper
• Plasma androgens, IGF-1, body size, and prostate cancer risk: a synthetic review

  2000cited by this paper
• Anthropometry and prostate cancer risk: a prospective study of 22,248 Norwegian men

  1999cited by this paper
• Risk factors for prostate cancer: results from the Canadian National Enhanced Cancer Surveillance System

  1999cited by this paper
• Circulating IGF-I: New Perspectives for a New Century.

  1999cited by this paper
• Response: More About: Prospective Study of Colorectal Cancer Risk in Men and Plasma Levels of Insulin-Like Growth Factor (IGF)-I and IGF- Binding Protein-3

  1999cited by this paper
• Growth hormone in obesity

  1999cited by this paper
• REVIEW Dietary Fat and Prostate Cancer: Current Status

  1999cited by this paper
• Determinants of circulating insulin-like growth factor-I.

  1999cited by this paper
• Smoking and risk of total and fatal prostate cancer in United States health professionals.

  1999cited by this paper
• Energy intake and prostate tumor growth, angiogenesis, and vascular endothelial growth factor expression.

  1999cited by this paper
• Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3.

  1999cited by this paper
• Leptin is associated with increased risk of myocardial infarction

  1999cited by this paper
• Cancer cell lines

  1999cited by this paper
• Insulin-like growth factor 1 and prostate cancer risk: a population-based, case-control study.

  1998influential reference
• Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study.

  1998influential reference
• Circulating concentrations of insulin-like growth factor-I and risk of breast cancer.

  1998cited by this paper
• Insulin-like growth factor 1 in relation to prostate cancer and benign prostatic hyperplasia.

  1997cited by this paper
• Free insulin-like growth factor I (IGF-I) in healthy subjects: relationship with IGF-binding proteins and insulin sensitivity.

  1997cited by this paper
• Effect of obesity on total and free insulin-like growth factor (IGF)-1, and their relationship to IGF-binding protein (BP)-1, IGFBP-2, IGFBP-3, insulin, and growth hormone

  1997cited by this paper
• Height, body weight, and risk of prostate cancer.

  1997cited by this paper
• Epidemiology of insulin-like growth factor-I in elderly men and women. The Rancho Bernardo Study.

  1997cited by this paper
• Dietary restriction reduces insulin-like growth factor I levels, which modulates apoptosis, cell proliferation, and tumor progression in p53-deficient mice.

  1997cited by this paper
• Insulin-like growth factor-binding proteins in serum and other biological fluids: regulation and functions.

  1997cited by this paper
• Risk factors for malignant diseases: a cohort study on a population of 22,946 Icelanders.

  1997cited by this paper
• Body size and prostate cancer: a 20-year follow-up study among 135006 Swedish construction workers.

  1997cited by this paper
• Cigarette smoking as a predictor of death from prostate cancer in 348,874 men screened for the Multiple Risk Factor Intervention Trial.

  1996cited by this paper
• Genetic and environmental components of interindividual variation in circulating levels of IGF-I, IGF-II, IGFBP-1, and IGFBP-3.

  1996cited by this paper
• Physiological regulation of the human growth hormone (GH)-insulin-like growth factor type I (IGF-I) axis: predominant impact of age, obesity, gonadal function, and sleep.

  1996cited by this paper
• Serum leptin levels in women with anorexia nervosa.

  1996cited by this paper
• Prostate cancer and smoking: A review of case‐control and cohort studies

  1996cited by this paper
• Insulin-like growth factor bioactivity and its modification in growth hormone resistant states.

  1996cited by this paper
• Total food consumption and body mass index in relation to prostate cancer risk: a case-control study in Sweden with prospectively collected exposure data.

  1996cited by this paper
• C-peptide, insulin-like growth factors I and II, and insulin-like growth factor binding protein-1 in cord serum of twins: genetic versus environmental regulation.

  1996cited by this paper
• Quantitative genetic analyses of insulin-like growth factor I (IGF-I), IGF-binding protein-1, and insulin levels in middle-aged and elderly twins.

  1996cited by this paper
• Insulin-like growth factor-binding proteins (IGFBPs) and their regulatory dynamics.

  1996cited by this paper
• Reliability of serum hormones in premenopausal and postmenopausal women over a one-year period.

  1996cited by this paper
• Insulin-like growth factors and their binding proteins: biological actions.

  1995influential reference
• Prostate cancer in relation to diet, physical activity, and body size in blacks, whites, and Asians in the United States and Canada.

  1995cited by this paper
• Serum insulin-like growth factor-I in 1030 healthy children, adolescents, and adults: relation to age, sex, stage of puberty, testicular size, and body mass index.

  1994cited by this paper
• Nutritional regulation of the insulin-like growth factors.

  1994influential reference
• Dominant negative inhibition of tumorigenesis in vivo by human insulin-like growth factor I receptor mutant.

  1994cited by this paper
• The ratio between serum levels of insulin‐like growth factor (IGF)‐I and the IGF binding proteins (IGFBP‐1, 2 and 3) decreases with age in healthy adults and is increased in acromegalic patients

  1994cited by this paper
• Insulin‐like growth factor I: Action and receptor characterization in human prostate cancer cell lines

  1993cited by this paper
• Evaluation of the Abbott IMx automated immunoassay of prostate-specific antigen.

  1992cited by this paper
• The effect of anorexia nervosa and refeeding on growth hormone-binding protein, the insulin-like growth factors (IGFs), and the IGF-binding proteins.

  1992cited by this paper
• Insulin-like growth factors (IGFs), IGF receptors, and IGF-binding proteins in primary cultures of prostate epithelial cells.

  1991cited by this paper
• Renal, metabolic and hormonal responses to ingestion of animal and vegetable proteins.

  1990cited by this paper
• Prevention of prostate cancer and liver tumors in L‐W rats by moderate dietary restriction

  1989cited by this paper
• International comparisons of mortality rates for cancer of the breast, ovary, prostate, and colon, and per capita food consumption

  1986cited by this paper
• Supplemental essential amino acids augment the somatomedin-C/insulin-like growth factor I response to refeeding after fasting.

  1985cited by this paper
• Completeness of the Swedish Cancer Register. Non-notified cancer cases recorded on death certificates in 1978.

  1984cited by this paper
• Changes in plasma somatomedin-C in response to ingestion of diets with variable protein and energy content.

  1984cited by this paper
• International Histological Classification of Tumours

  1981cited by this paper

• Serum insulin-like growth factor-1 and epidemiological evidence of the risk of prostate cancer

  2026cites this paper
• Molecular targeted therapies, omics, and AI based theranostics approaches for the treatment of prostate cancer.

  2025cites this paper
• Feasibility and acceptability of a personalised primary prevention strategy for women and men at high risk of breast and prostate cancer: the 3PC study protocol for a pilot randomised controlled trial

  2025cites this paper
• New findings on the effects of diabetes and anti-diabetic drugs on prostate cancer.

  2024cites this paper
• Insulin-like growth factor family and prostate cancer: new insights and emerging opportunities

  2024cites this paper
• The issues and challenges with cancer biomarkers

  2023cites this paper
• Tip 2 Diyabetik Hastalarda Serum Prostat Spesifik Antijenin Değerledirilmesi The Assesment of Serum Prostate Specific Antigen in Type 2 Diabetic Patients

  2023cites this paper
• Synthetic Retinoids as Potential Therapeutics in Prostate Cancer—An Update of the Last Decade of Research: A Review

  2021cites this paper
• Inflammatory and Insulinemic Dietary Patterns: Influence on Circulating Biomarkers and Prostate Cancer Risk

  2020cites this paper
• A meta-analysis

  2019cites this paper
• Epidemiology of Prostate Cancer

  2019cites this paper
• Absence of excess body fatness

  2019cites this paper
• Phase I Study of IGF-Methotrexate Conjugate in the Treatment of Advanced Tumors Expressing IGF-1R

  2019cites this paper
• Carbohydrate Nutrition and the Risk of Cancer

  2019cites this paper
• The Impact of Combined (Aerobic-resistance) Training on Serum Levels of IGF-I and IGFBP-3 in Men with Prostate Cancer

  2019cites this paper
• Association between insulin-like growth factor 1 gene rs35767 polymorphisms and cancer risk

  2019cites this paper
• Serum insulin level, HOMA-IR and prostate cancer risk: A systematic review and meta-analysis.

  2019cites this paper
• Dietary Carcinogens and DNA Adducts in Prostate Cancer.

  2019cites this paper
• The associations of anthropometric, behavioural and sociodemographic factors with circulating concentrations of IGF‐I, IGF‐II, IGFBP‐1, IGFBP‐2 and IGFBP‐3 in a pooled analysis of 16,024 men from 22 studies

  2019cites this paper
• Circulating vitamin D concentration and risk of prostate cancer: a dose–response meta-analysis of prospective studies

  2018cites this paper
• Adult height and all-cause and cause-specific mortality in the Japan Public Health Center-based Prospective Study (JPHC)

  2018cites this paper
• Systemic Complications of Acromegaly and the Impact of the Current Treatment Landscape: An Update.

  2018cites this paper
• Untersuchungen zur Bedeutung zellulärer Regulationsprozesse des Aktivierungsstatus von mTOR und 4E‑BP1 und ihre Auswirkungen auf Tumorgenese und Progression des Prostatakarzinoms - Immunhistochemische Untersuchungen mittels der tissue microarray Technik

  2018cites this paper
• Recombinant human growth hormone: a medical miracle or cause for concern?

  2018cites this paper
• The effects of obesity-related hormones on cancer cells

  2018cites this paper
• Higher IGFBP3 is associated with increased incidence of colorectal cancer in older men independently of IGF1

  2018cites this paper
• Growth hormone-releasing hormone (GHRH) and its agonists inhibit hepatic and tumoral secretion of IGF-1

  2018cites this paper
• Serum C-peptide concentration and prostate cancer

  2018cites this paper
• Prostate-Specific Antigen as a Marker of Disease Activity in Prostate Cancer : Part 1 Review

  2017cites this paper
• Regulation of cell signaling pathways by dietary agents for cancer prevention and treatment.

  2017cites this paper
• Does milk intake promote prostate cancer initiation or progression via effects on insulin-like growth factors (IGFs)? A systematic review and meta-analysis

  2017cites this paper
• BOLOGICAL MARKERS FOR LONGEVITY AND DISEASES AND USES THEREOF

  2017cites this paper
• The role of IGF-1 and the distribution of body fat in decreasing the number of prostate rebiopsies ☆

  2017cites this paper
• The role of IGF-1 and the distribution of body fat in decreasing the number of prostate rebiopsies.

  2017cites this paper
• Growth Hormone Replacement Therapy in Adult Growth Hormone Deficiency and Risk of Cancer: A Meta-Analysis

  2017cites this paper
• Height, selected genetic markers and prostate cancer risk: results from the PRACTICAL consortium

  2017cites this paper
• The ovarian cancer oncobiome

  2017cites this paper
• Multiplexed MRM‐based assays for the quantitation of proteins in mouse plasma and heart tissue

  2017cites this paper
• Prostate cancer and bone cell interactions : implications for metastatic growth and therapy

  2017cites this paper
• Height, selected genetic markers and prostate cancer risk: results from the PRACTICAL consortium

  2017cites this paper
• Title Higher IGFB 3 is associated with increased incidence of colorectal cancer in older men independently of IGF 1 Short title IGF 1 , its binding proteins and cancer incidence

  2017cites this paper
• Fasting blood glucose and risk of prostate cancer: A systematic review and meta-analysis of dose-response.

  2017influential citation
• Plasma-free amino acid profiles are predictors of cancer and diabetes development

  2017cites this paper
• (2016). A meta-analysis of individual participant data reveals an association between circulating levels of IGF-I and prostate risk.

  2016cites this paper
• AN UPDATE ON THE RISK FACTORS FOR PROSTATE CANCER

  2016cites this paper
• Are strict vegetarians protected against prostate cancer?

  2016cites this paper
• Obesity and Prostate Cancer.

  2016cites this paper
• IGF1R and c-met as therapeutic targets for colorectal cancer.

  2016cites this paper
• A Meta-analysis of Individual Participant Data Reveals an Association between Circulating Levels of IGF-I and Prostate Cancer Risk.

  2016influential citation
• Ewing sarcoma: The clinical relevance of the insulin-like growth factor 1 and the poly-ADP-ribose-polymerase pathway.

  2016cites this paper
• Insulin‐like growth factor I and risk of incident cancer in elderly men – results from MrOS (Osteoporotic Fractures in Men) in Sweden

  2016cites this paper
• Crk II silencing down-regulates IGF-IR and inhibits migration and invasion of prostate cancer cells

  2016cites this paper
• Obesity Biomarkers, Metabolism and Risk of Cancer: An Epidemiological Perspective.

  2016cites this paper
• Fertility Conditions Associated with Cancer Development

  2016cites this paper
• Untargeted Metabolomic Analysis of Human Plasma Indicates Differentially Affected Polyamine and L-Arginine Metabolism in Mild Cognitive Impairment Subjects Converting to Alzheimer’s Disease

  2015cites this paper
• Insulin-Like growth factor 1 related pathways and high-fat diet promotion of transgenic adenocarcinoma mouse prostate (TRAMP) cancer progression.

  2015cites this paper
• Prediagnostic plasma IGFBP‐1, IGF‐1 and risk of prostate cancer

  2015cites this paper
• Association of circulating insulin-like growth factor 1 and insulin-like growth factor binding protein 3 with the risk of ovarian cancer: A systematic review and meta-analysis.

  2015cites this paper
• Insulin-Like growth factor 1 related pathways and high-fat diet promotion of transgenic adenocarcinoma mouse prostate (TRAMP) cancer progression.

  2015cites this paper
• Diabetes mellitus and the risk of prostate cancer: an update and cumulative meta-analysis

  2015cites this paper
• Dairy intake after prostate cancer diagnosis in relation to disease‐specific and total mortality

  2015cites this paper
• Are strict vegetarians protected against prostate cancer ? 1

  2015cites this paper
• The Insulin/IGF System in Colorectal Cancer Development and Resistance to Therapy

  2015cites this paper
• Regulation of IGF-1 receptor signaling by autophagy in human neuroblastoma cell lines

  2014cites this paper
• Type 2 diabetes: a protective factor for prostate cancer? An overview of proposed mechanisms.

  2014cites this paper
• Positive association between circulating 25-hydroxyvitamin D levels and prostate cancer risk: new findings from an updated meta-analysis

  2014cites this paper
• Phase 1b study of safety, tolerability and efficacy of R1507, a monoclonal antibody to IGF-1R in combination with multiple standard oncology regimens in patients with advanced solid malignancies

  2014cites this paper
• Serum glucose and risk of cancer: a meta-analysis

  2014cites this paper
• Metformin and Prostate Cancer among Diabetic Men

  2014cites this paper
• Chapter 13 – Impact of Rye Food and Physical Activity on Prostate Cancer Progression

  2014cites this paper
• The secret life of nuclear IGF-1R : functions beyond traditional signaling pathways

  2014cites this paper
• GCN2 and FGF21 are likely mediators of the protection from cancer, autoimmunity, obesity, and diabetes afforded by vegan diets.

  2014cites this paper
• ' s response to reviews Title : Serum glucose and risk of cancer : A Meta-analysis

  2014cites this paper
• Whole Grain and Dietary Fiber Intake and Risk of Prostate Cancer

  2014cites this paper
• Targeting the insulin-like growth factor-1 receptor in human cancer

  2013cites this paper
• The Role of Dairy Products in Prostate Cancer: A Review

  2013cites this paper
• Insulin-Like Growth Factors and Insulin-Like Growth Factor–Binding Proteins and Prostate Cancer Risk: Results from the Prostate Cancer Prevention Trial

  2013cites this paper
• MOLECULAR EVENTS UNDERPINNING CHANGES IN TISSUE METABOLISM WITH WHEY AND SOY PROTEIN INGESTION IN ENERGY RESTRICTION IN OVERWEIGHT/OBESE ADULTS

  2013cites this paper
• CLONING OF UBAP 2 AND ITS ROLE IN PROSTATE CANCER

  2013cites this paper
• Transforming Growth Factor-Beta in Prostate Cancer

  2013cites this paper
• Weight control and cancer preventive mechanisms: Role of insulin growth factor-1-mediated signaling pathways

  2013cites this paper
• Evidence for the Possible Biological Significance of the igf-1 Gene Alternative Splicing in Prostate Cancer

  2013cites this paper
• Sex-specific associations between body mass index, waist circumference and the risk of Barrett's oesophagus: a pooled analysis from the international BEACON consortium

  2013cites this paper
• MANAGEMENT OF ENDOCRINE DISEASE: GH therapy and cancer risk in hypopituitarism: what we know from human studies

  2013cites this paper
• Prostate Cancer

  2013cites this paper
• Epidemiology of Prostate Cancer

  2013cites this paper
• Diabetes and cancer: two diseases with obesity as a common risk factor

  2013cites this paper
• Pleiotropy between Genetic Markers of Obesity and Risk of Prostate Cancer

  2013cites this paper
• Targeting EGFR and IGF 1R: a promising combination therapy for metastatic cancer.

  2013cites this paper
• Maternal BMI, IGF-I Levels, and Birth Weight in African American and White Infants

  2013cites this paper
• Expression of growth hormone and growth hormone receptor in fibroadenomas of the breast.

  2013cites this paper
• Value of serum and bile levels of IGF-1 in discriminating cholangiocarcinoma from other causes of extrahepatic biliary obstruction

  2013cites this paper
• Epidemiology of IGF-1 and Cancer

  2012cites this paper
• Lycopene modulation of molecular targets affected by smoking exposure.

  2012cites this paper
• A feasibility study of a home-based exercise intervention for prostate cancer patients on androgen deprivation therapy

  2012cites this paper
• Zinc and Cancer: Implications for LIV-1 in Breast Cancer

  2012cites this paper
• Circulating insulin-like growth factors and IGF-binding proteins in PSA-detected prostate cancer: the large case-control study ProtecT.

  2012cites this paper
• Human Growth Hormone and Insulin‐Like Growth Factor

  2012cites this paper
• Cancer Cell Signaling Pathways Targeted by Spice-Derived Nutraceuticals

  2012cites this paper
• Preoperative insulin‐like growth factor‐binding protein‐3 (IGFBP‐3) blood level predicts gleason sum upgrading

  2012cites this paper